首页 > 最新文献

Frontiers in Psychiatry最新文献

英文 中文
Effects of electroconvulsive therapy on inflammatory markers and depressive symptoms in adolescents with major depressive disorder. 电休克疗法对重度抑郁症青少年炎症标志物和抑郁症状的影响。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1447839
Ning Du, Yvna Wang, Dandan Geng, Huan Chen, Fengming Chen, Li Kuang, Jiamei Guo

Objective: Limited research exists on the use of electroconvulsive therapy (ECT) for adolescents with major depressive disorder (MDD). This study investigates the effects of ECT on inflammatory markers in adolescents aged 13-18 suffering from severe MDD, evaluating its efficacy in modulating cellular inflammatory markers and ameliorating depressive symptoms.

Methods: A cohort of 38 adolescents with severe MDD received standard antidepressant therapy along with 6-8 ECT sessions spanning two weeks. A control group of 29 age-matched, healthy individuals was also assessed for comparative purposes. The investigation measured variations in depressive symptomatology and inflammatory marker levels (IL-1β, IL-6, IL-10) pre- and post-intervention.

Results: Post-ECT, a substantial decrease in pro-inflammatory cytokines (IL-1β and IL-6) and an increase in the anti-inflammatory cytokine (IL-10) were noted. Participants who responded to the treatment showed a significant decline in HAMD-17 scores, which accentuates ECT's therapeutic potential. Comparative analysis indicated a significant correlation between post-treatment inflammatory marker alterations and clinical improvement, implying that shifts in inflammatory state might serve as predictors of treatment response. Moreover, the mitigation of depressive symptoms exhibited a moderate correlation with post-treatment decrements in IL-1β and IL-6 levels, underscoring MDD's intricacy and ECT's comprehensive impact.

Conclusion: While initial inflammatory marker levels did not predict the response to ECT, the post-treatment measures appeared to be linked to clinical improvement. These findings suggest ECT's potential effectiveness in treating severe MDD in adolescents and point to the possible predictive value of inflammatory markers in therapeutic outcomes. The study contributes to our understanding of the biopsychosocial framework of MDD and indicates that ECT may be a viable treatment option for this population.

目的:对患有重度抑郁症(MDD)的青少年使用电休克疗法(ECT)的研究有限。本研究调查了电休克疗法对13-18岁患有严重MDD的青少年炎症标志物的影响,评估其在调节细胞炎症标志物和改善抑郁症状方面的疗效:方法:38 名患有严重 MDD 的青少年在接受标准抗抑郁治疗的同时,还接受了为期两周的 6-8 次 ECT 治疗。为了进行比较,还对由 29 名年龄匹配的健康人组成的对照组进行了评估。调查测量了干预前后抑郁症状和炎症标志物水平(IL-1β、IL-6、IL-10)的变化:结果:干预后,促炎细胞因子(IL-1β 和 IL-6)大幅下降,抗炎细胞因子(IL-10)上升。对治疗有反应的参与者的 HAMD-17 评分显著下降,这凸显了 ECT 的治疗潜力。对比分析表明,治疗后炎症标志物的改变与临床改善之间存在明显的相关性,这意味着炎症状态的变化可能是治疗反应的预测因素。此外,抑郁症状的缓解与治疗后IL-1β和IL-6水平的下降呈中度相关,这凸显了MDD的复杂性和ECT的综合影响:结论:虽然最初的炎症标志物水平不能预测对 ECT 的反应,但治疗后的指标似乎与临床改善有关。这些研究结果表明,ECT在治疗青少年严重MDD方面具有潜在的有效性,并指出炎症标志物在治疗结果中可能具有预测价值。这项研究有助于我们了解多发性硬化症的生物心理社会框架,并表明ECT可能是这一人群的可行治疗方案。
{"title":"Effects of electroconvulsive therapy on inflammatory markers and depressive symptoms in adolescents with major depressive disorder.","authors":"Ning Du, Yvna Wang, Dandan Geng, Huan Chen, Fengming Chen, Li Kuang, Jiamei Guo","doi":"10.3389/fpsyt.2024.1447839","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1447839","url":null,"abstract":"<p><strong>Objective: </strong>Limited research exists on the use of electroconvulsive therapy (ECT) for adolescents with major depressive disorder (MDD). This study investigates the effects of ECT on inflammatory markers in adolescents aged 13-18 suffering from severe MDD, evaluating its efficacy in modulating cellular inflammatory markers and ameliorating depressive symptoms.</p><p><strong>Methods: </strong>A cohort of 38 adolescents with severe MDD received standard antidepressant therapy along with 6-8 ECT sessions spanning two weeks. A control group of 29 age-matched, healthy individuals was also assessed for comparative purposes. The investigation measured variations in depressive symptomatology and inflammatory marker levels (IL-1β, IL-6, IL-10) pre- and post-intervention.</p><p><strong>Results: </strong>Post-ECT, a substantial decrease in pro-inflammatory cytokines (IL-1β and IL-6) and an increase in the anti-inflammatory cytokine (IL-10) were noted. Participants who responded to the treatment showed a significant decline in HAMD-17 scores, which accentuates ECT's therapeutic potential. Comparative analysis indicated a significant correlation between post-treatment inflammatory marker alterations and clinical improvement, implying that shifts in inflammatory state might serve as predictors of treatment response. Moreover, the mitigation of depressive symptoms exhibited a moderate correlation with post-treatment decrements in IL-1β and IL-6 levels, underscoring MDD's intricacy and ECT's comprehensive impact.</p><p><strong>Conclusion: </strong>While initial inflammatory marker levels did not predict the response to ECT, the post-treatment measures appeared to be linked to clinical improvement. These findings suggest ECT's potential effectiveness in treating severe MDD in adolescents and point to the possible predictive value of inflammatory markers in therapeutic outcomes. The study contributes to our understanding of the biopsychosocial framework of MDD and indicates that ECT may be a viable treatment option for this population.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of preoperative and postoperative depression and anxiety in patients with lumbar disc herniation with radiculopathy treated with percutaneous transforaminal endoscopic discectomy. 经皮椎间孔内窥镜椎间盘切除术治疗腰椎间盘突出症伴根性病变患者术前和术后抑郁与焦虑分析。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1460274
Yatao Wei, Hailun Huang, Kui Sun, Heng Gao, Zhenwen Cao, Bin Zhang, Junzhe Wu, Yongai Liu

Objective: This study aims to examine the mental health of patients with lumbar disc herniation with radiculopathy (LDHR) and to evaluate the effects of percutaneous transforaminal endoscopic discectomy (PTED) on their mental well-being.

Method: This study included 114 LDHR patients who received PTED in the Spinal Orthopedics Department of Zhongshan Hospital of Traditional Chinese Medicine between May 2022 and May 2023. The study population was stratified into two groups according to the presence of preoperative anxiety and depression: Group A comprised patients with such symptoms, and Group B included the remainder. Patients were assessed using the Hospital Anxiety and Depression Scale (HADS), the Visual Analog Scale for Pain (VAS), and the Oswestry Disability Index (ODI) at preoperative and final follow-up visits. Evaluations were performed using the Hospital Anxiety and Depression Scale (HADS), the Visual Analog Scale, and the Oswestry Disability Index (ODI) at the time of preoperation and during the last follow-up.

Results: Among the 114 LDHR patients who obtained complete follow-up, fifty-four had anxiety/depression symptoms before surgery, which accounted for a incidence of 47%. Both Group A and Group B patients showed significant improvement in all evaluation indicators after PTED, but the overall prognosis of Group A was worse than that of Group B.

Conclusion: PTED can effectively improve patients' pain, functional activities and mental health, which has a positive impact on patients' quality of life, and there is a significant correlation between patients' preoperative mental health and prognosis.

研究目的本研究旨在探讨腰椎间盘突出症伴根性病变(LDHR)患者的心理健康状况,并评估经皮椎间孔镜椎间盘切除术(PTED)对患者心理健康的影响:本研究纳入了2022年5月至2023年5月期间在中山市中医院脊柱骨科接受PTED治疗的114名LDHR患者。研究人群根据术前焦虑和抑郁的存在情况分为两组:A组包括有此类症状的患者,B组包括其余患者。在术前和最终随访时,使用医院焦虑抑郁量表(HADS)、疼痛视觉模拟量表(VAS)和Oswestry残疾指数(ODI)对患者进行评估。在术前和最后一次随访时使用医院焦虑抑郁量表(HADS)、疼痛视觉模拟量表和 Oswestry 残疾指数(ODI)进行评估:在获得完整随访的 114 名 LDHR 患者中,54 人在手术前有焦虑/抑郁症状,占 47%。A组和B组患者在PTED术后各项评估指标均有明显改善,但A组的总体预后差于B组:PTED能有效改善患者的疼痛、功能活动和心理健康,对患者的生活质量有积极影响,患者术前的心理健康与预后有显著相关性。
{"title":"Analysis of preoperative and postoperative depression and anxiety in patients with lumbar disc herniation with radiculopathy treated with percutaneous transforaminal endoscopic discectomy.","authors":"Yatao Wei, Hailun Huang, Kui Sun, Heng Gao, Zhenwen Cao, Bin Zhang, Junzhe Wu, Yongai Liu","doi":"10.3389/fpsyt.2024.1460274","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1460274","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to examine the mental health of patients with lumbar disc herniation with radiculopathy (LDHR) and to evaluate the effects of percutaneous transforaminal endoscopic discectomy (PTED) on their mental well-being.</p><p><strong>Method: </strong>This study included 114 LDHR patients who received PTED in the Spinal Orthopedics Department of Zhongshan Hospital of Traditional Chinese Medicine between May 2022 and May 2023. The study population was stratified into two groups according to the presence of preoperative anxiety and depression: Group A comprised patients with such symptoms, and Group B included the remainder. Patients were assessed using the Hospital Anxiety and Depression Scale (HADS), the Visual Analog Scale for Pain (VAS), and the Oswestry Disability Index (ODI) at preoperative and final follow-up visits. Evaluations were performed using the Hospital Anxiety and Depression Scale (HADS), the Visual Analog Scale, and the Oswestry Disability Index (ODI) at the time of preoperation and during the last follow-up.</p><p><strong>Results: </strong>Among the 114 LDHR patients who obtained complete follow-up, fifty-four had anxiety/depression symptoms before surgery, which accounted for a incidence of 47%. Both Group A and Group B patients showed significant improvement in all evaluation indicators after PTED, but the overall prognosis of Group A was worse than that of Group B.</p><p><strong>Conclusion: </strong>PTED can effectively improve patients' pain, functional activities and mental health, which has a positive impact on patients' quality of life, and there is a significant correlation between patients' preoperative mental health and prognosis.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bullying of LGBTQ+ children and adolescents in schools: understanding the phenomenon, consequences, and international standards with a focus on the polish context. 校内对 LGBTQ+ 儿童和青少年的欺凌:了解现象、后果和国际标准,重点关注波兰的情况。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1493745
Bartłomiej Stańczykiewicz, Adrianna Senczyszyn

Bullying refers to repetitive, aggressive behavior intended to harm or intimidate others. Cyberbullying extends this aggression to digital platforms, involving harassment via social media, texts, or emails. These forms of bullying are particularly damaging to LGBTQ+ youth, who often face discrimination based on their sexual orientation or gender identity. In the context of LGBTQ+ individuals, bullying and cyberbullying can lead to severe emotional and psychological harm, contributing to higher rates of depression, anxiety, and suicidal ideation. Despite extensive global efforts and campaigns to combat homophobia, LGBTQ+ students continue to face significant challenges, with the situation in Poland being notably severe. The review highlights various forms of bullying, including physical, verbal, and social aggression, and underscores the alarming involvement of school personnel in perpetuating such behaviors. The focus on the Polish context enriches the global discourse on LGBTQ+ rights and highlights the critical need for targeted interventions to support vulnerable youth in regions with prevalent conservative and religious sentiments.

欺凌是指旨在伤害或恐吓他人的重复性、攻击性行为。网络欺凌将这种攻击行为扩展到数字平台,涉及通过社交媒体、短信或电子邮件进行骚扰。这些形式的欺凌对 LGBTQ+ 青年的伤害尤为严重,因为他们经常面临基于性取向或性别认同的歧视。就 LGBTQ+ 个人而言,欺凌和网络欺凌可导致严重的情感和心理伤害,导致抑郁、焦虑和自杀倾向的发生率升高。尽管全球在打击仇视同性恋现象方面做出了广泛的努力并开展了各种运动,但 LGBTQ+ 学生仍然面临着巨大的挑战,其中波兰的情况尤为严重。本报告重点介绍了各种形式的欺凌行为,包括肢体、语言和社交攻击,并强调了学校工作人员参与此类行为的情况令人震惊。对波兰情况的关注丰富了全球关于 LGBTQ+ 权利的讨论,并强调了在保守和宗教情绪盛行的地区,亟需采取有针对性的干预措施来支持弱势青年。
{"title":"Bullying of LGBTQ+ children and adolescents in schools: understanding the phenomenon, consequences, and international standards with a focus on the polish context.","authors":"Bartłomiej Stańczykiewicz, Adrianna Senczyszyn","doi":"10.3389/fpsyt.2024.1493745","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1493745","url":null,"abstract":"<p><p>Bullying refers to repetitive, aggressive behavior intended to harm or intimidate others. Cyberbullying extends this aggression to digital platforms, involving harassment via social media, texts, or emails. These forms of bullying are particularly damaging to LGBTQ+ youth, who often face discrimination based on their sexual orientation or gender identity. In the context of LGBTQ+ individuals, bullying and cyberbullying can lead to severe emotional and psychological harm, contributing to higher rates of depression, anxiety, and suicidal ideation. Despite extensive global efforts and campaigns to combat homophobia, LGBTQ+ students continue to face significant challenges, with the situation in Poland being notably severe. The review highlights various forms of bullying, including physical, verbal, and social aggression, and underscores the alarming involvement of school personnel in perpetuating such behaviors. The focus on the Polish context enriches the global discourse on LGBTQ+ rights and highlights the critical need for targeted interventions to support vulnerable youth in regions with prevalent conservative and religious sentiments.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness analysis of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary mental health care settings alongside a randomized controlled trial. 基于正念的认知疗法对二级精神医疗机构焦虑症患者的成本效益分析以及随机对照试验。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1391786
Mitsuhiro Sado, Akihiro Koreki, Akira Ninomiya, Chika Kurata, Sunre Park, Daisuke Fujisawa, Teppei Kosugi, Maki Nagaoka, Atsuo Nakagawa, Masaru Mimura

Introduction: Anxiety disorder is one of the most prevalent mental disorders. Mindfulness-based cognitive therapy (MBCT) is effective for treating anxiety disorders. However, no studies have investigated the cost-effectiveness of MBCT for anxiety disorders. We aimed to conduct a cost-effectiveness analysis alongside a randomized controlled trial (RCT) to clarify the cost-effectiveness of MBCT for anxiety disorders.

Methods: A cost-effectiveness analysis alongside an RCT was conducted for 8 weeks in 40 patients with anxiety disorders at a university hospital. Patients (1) aged 20-75 years; (2) who were diagnosed with panic disorder/agoraphobia or social anxiety disorder based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria; and (3) who provided written consent were analyzed. The participants were allocated randomly (1:1 ratio) to the augmented MBCT group (i.e., MBCT plus treatment as usual [TAU]) or TAU (waitlist control) group. The cost-effectiveness was assessed using the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental costs divided by the incremental state-trait anxiety inventory- state (STAI-S), state-trait anxiety inventory- trait (STAI-T), and quality-adjusted life years (QALYs). The QALYs were estimated using The Japanese version of EuroQoL five-dimensional 3-level questionnaire. The unit cost data were derived from the government-regulated fees. This study was conducted from a public healthcare insurance perspective. No discount rates were considered.

Results: A total of 38 participants with complete data were included in the analysis. The MBCT was JPY 13,885 more than the cost of TAU and was associated with a STAI-S, STAI-T, and QALY increase of 10.13, 12.00, 0.009 respectively. The ICER were JPY 1,371 (USD13) per STAI-S, JPY 1,157 (USD 11) per STAI-T, and JPY 1,566,357 (USD 14,940) per QALY respectively. MBCT had an 77.5% probability of being cost-effective at a willingness to pay threshold in Japan (JPY 5,000,000 per QALY). The results of the four one-way sensitivity analyses supported the robustness of the base-case analysis findings.

Discussion: Augmented MBCT for anxiety disorders is cost-effective compared with TAU post-treatment from a public healthcare insurance perspective. Future studies should include long-term observations, and analysis from a societal perspective.

简介焦虑症是最常见的精神障碍之一。正念认知疗法(MBCT)可有效治疗焦虑症。然而,还没有研究调查过基于正念的认知疗法治疗焦虑症的成本效益。我们的目的是在进行随机对照试验(RCT)的同时进行成本效益分析,以明确MBCT治疗焦虑症的成本效益:在进行 RCT 的同时,我们还对一家大学医院的 40 名焦虑症患者进行了为期 8 周的成本效益分析。被分析的患者(1)年龄在 20-75 岁之间;(2)根据《精神疾病诊断与统计手册》第四版的标准被诊断为恐慌症/广场恐惧症或社交焦虑症;(3)提供了书面同意书。参与者被随机(1:1 比例)分配到增强型 MBCT 组(即 MBCT 加常规治疗 [TAU])或 TAU(候补对照)组。成本效益采用增量成本效益比(ICER)进行评估,即增量成本除以增量状态-特质焦虑清单-状态(STAI-S)、状态-特质焦虑清单-特质(STAI-T)和质量调整生命年(QALYs)的比率。QALYs 是使用日文版 EuroQoL 五维三级问卷估算的。单位成本数据来自政府规定的费用。本研究从公共医疗保险的角度进行。研究未考虑贴现率:共有 38 名数据完整的参与者参与了分析。MBCT 比 TAU 的费用高出 13,885 日元,STAI-S、STAI-T 和 QALY 分别增加了 10.13、12.00 和 0.009。每 STAI-S 的 ICER 分别为 1,371 日元(13 美元),每 STAI-T 的 ICER 分别为 1,157 日元(11 美元),每 QALY 的 ICER 分别为 1,566,357 日元(14,940 美元)。根据日本的支付意愿阈值(每 QALY 5,000,000 日元),MBCT 符合成本效益的概率为 77.5%。四项单向敏感性分析的结果支持了基础案例分析结果的稳健性:讨论:从公共医疗保险的角度来看,与TAU治疗后相比,增强型MBCT治疗焦虑症具有成本效益。未来的研究应包括长期观察和社会角度的分析。
{"title":"Cost-effectiveness analysis of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary mental health care settings alongside a randomized controlled trial.","authors":"Mitsuhiro Sado, Akihiro Koreki, Akira Ninomiya, Chika Kurata, Sunre Park, Daisuke Fujisawa, Teppei Kosugi, Maki Nagaoka, Atsuo Nakagawa, Masaru Mimura","doi":"10.3389/fpsyt.2024.1391786","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1391786","url":null,"abstract":"<p><strong>Introduction: </strong>Anxiety disorder is one of the most prevalent mental disorders. Mindfulness-based cognitive therapy (MBCT) is effective for treating anxiety disorders. However, no studies have investigated the cost-effectiveness of MBCT for anxiety disorders. We aimed to conduct a cost-effectiveness analysis alongside a randomized controlled trial (RCT) to clarify the cost-effectiveness of MBCT for anxiety disorders.</p><p><strong>Methods: </strong>A cost-effectiveness analysis alongside an RCT was conducted for 8 weeks in 40 patients with anxiety disorders at a university hospital. Patients (1) aged 20-75 years; (2) who were diagnosed with panic disorder/agoraphobia or social anxiety disorder based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria; and (3) who provided written consent were analyzed. The participants were allocated randomly (1:1 ratio) to the augmented MBCT group (i.e., MBCT plus treatment as usual [TAU]) or TAU (waitlist control) group. The cost-effectiveness was assessed using the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental costs divided by the incremental state-trait anxiety inventory- state (STAI-S), state-trait anxiety inventory- trait (STAI-T), and quality-adjusted life years (QALYs). The QALYs were estimated using The Japanese version of EuroQoL five-dimensional 3-level questionnaire. The unit cost data were derived from the government-regulated fees. This study was conducted from a public healthcare insurance perspective. No discount rates were considered.</p><p><strong>Results: </strong>A total of 38 participants with complete data were included in the analysis. The MBCT was JPY 13,885 more than the cost of TAU and was associated with a STAI-S, STAI-T, and QALY increase of 10.13, 12.00, 0.009 respectively. The ICER were JPY 1,371 (USD13) per STAI-S, JPY 1,157 (USD 11) per STAI-T, and JPY 1,566,357 (USD 14,940) per QALY respectively. MBCT had an 77.5% probability of being cost-effective at a willingness to pay threshold in Japan (JPY 5,000,000 per QALY). The results of the four one-way sensitivity analyses supported the robustness of the base-case analysis findings.</p><p><strong>Discussion: </strong>Augmented MBCT for anxiety disorders is cost-effective compared with TAU post-treatment from a public healthcare insurance perspective. Future studies should include long-term observations, and analysis from a societal perspective.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel missense mutation in ISCA2 causes aberrant splicing and leads to multiple mitochondrial dysfunctions syndrome 4. ISCA2中的一种新型错义突变会导致剪接异常,并引发多线粒体功能障碍综合征4。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-18 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1428175
Zuhair Al-Hassnan, Mazhor AlDosary, Aljouhra AlHargan, Hanan AlQudairy, Rawan Almass, Khaled Omar Alahmadi, Saif AlShahrani, Albandary AlBakheet, Mohammad A Almuhaizea, Robert W Taylor, Dilek Colak, Namik Kaya

Background: Iron-sulfur cluster assembly 2 (ISCA2) deficiency is linked to an autosomal recessive disorder known as multiple mitochondrial dysfunctions syndrome 4 (MMDS4). This disorder is characterized by leukodystrophy and neuroregression. Currently, most of the reported patients are from Saudi Arabia. All these patients carry a homozygous founder variant (NM_194279.2:c.229G>A:p.Gly77Ser) in ISCA2.

Methods: We describe a patient who underwent full clinical evaluation, including metabolic, neurological, and radiological examinations. Standard genetic testing, including whole exome sequencing coupled with autozygome analysis, was undertaken, as were assessments of mitochondrial DNA (mtDNA) copy number and mtDNA sequencing on DNA extracted from blood and cultured fibroblasts. Functional workup consisted of splicing assessment of ISCA2 using RT-PCR, biochemical assessment of complex I status using dipstick assays, and mitochondrial respiration measurements using a Seahorse XFp analyzer.

Results: We present the clinical and functional characterization of a novel homozygous ISCA2 missense variant (NM_194279.3:c.70A>G:p.Arg24Gly), leading to aberrant splicing in a patient presenting with neuroregression, generalized spasticity with exaggerated deep tendon reflexes and head lag, and progressive loss of acquired milestones. The novel variant was fully segregated in a wider family and was absent in a large control cohort, ethnically matching in-house exomes, local databases such as CGMdb and Saudi Human Genome Program, and ClinVar.

Conclusions: Our analyses revealed that the variant is pathogenic, disrupting normal ISCA2 splicing and presumably leading to a truncated protein that disturbs metabolic pathways in patient-derived cells.

背景:铁硫簇组装 2(ISCA2)缺乏症与一种常染色体隐性遗传疾病有关,这种疾病被称为多线粒体功能障碍综合征 4(MMDS4)。这种疾病的特征是白营养不良和神经退化。目前,大多数报告的患者来自沙特阿拉伯。所有这些患者都携带 ISCA2 的同源基因变异(NM_194279.2:c.229G>A:p.Gly77Ser):我们对一名患者进行了全面的临床评估,包括代谢、神经和放射学检查。我们还对线粒体 DNA(mtDNA)拷贝数进行了评估,并对从血液和培养成纤维细胞中提取的 DNA 进行了 mtDNA 测序。功能检查包括使用 RT-PCR 评估 ISCA2 的剪接情况,使用浸量棒测定法对复合体 I 状态进行生化评估,以及使用 Seahorse XFp 分析仪测量线粒体呼吸:我们展示了一个新型同卵ISCA2错义变体(NM_194279.3:c.70A>G:p.Arg24Gly)的临床和功能特征,该变体导致患者出现神经退化、全身痉挛、深腱反射亢进和头部滞后,并逐渐丧失获得性发育里程碑。该新型变异在一个更广泛的家族中完全分离,而在一个大型对照队列、人种匹配的内部外显子组、CGMdb 和沙特人类基因组计划等本地数据库以及 ClinVar 中则不存在:我们的分析表明,该变异体是致病的,它破坏了正常的 ISCA2 剪接,并可能导致产生截短蛋白,从而扰乱患者细胞的代谢途径。
{"title":"A novel missense mutation in <i>ISCA2</i> causes aberrant splicing and leads to multiple mitochondrial dysfunctions syndrome 4.","authors":"Zuhair Al-Hassnan, Mazhor AlDosary, Aljouhra AlHargan, Hanan AlQudairy, Rawan Almass, Khaled Omar Alahmadi, Saif AlShahrani, Albandary AlBakheet, Mohammad A Almuhaizea, Robert W Taylor, Dilek Colak, Namik Kaya","doi":"10.3389/fpsyt.2024.1428175","DOIUrl":"10.3389/fpsyt.2024.1428175","url":null,"abstract":"<p><strong>Background: </strong>Iron-sulfur cluster assembly 2 (ISCA2) deficiency is linked to an autosomal recessive disorder known as multiple mitochondrial dysfunctions syndrome 4 (MMDS4). This disorder is characterized by leukodystrophy and neuroregression. Currently, most of the reported patients are from Saudi Arabia. All these patients carry a homozygous founder variant (NM_194279.2:c.229G>A:p.Gly77Ser) in <i>ISCA2</i>.</p><p><strong>Methods: </strong>We describe a patient who underwent full clinical evaluation, including metabolic, neurological, and radiological examinations. Standard genetic testing, including whole exome sequencing coupled with autozygome analysis, was undertaken, as were assessments of mitochondrial DNA (mtDNA) copy number and mtDNA sequencing on DNA extracted from blood and cultured fibroblasts. Functional workup consisted of splicing assessment of <i>ISCA2</i> using RT-PCR, biochemical assessment of complex I status using dipstick assays, and mitochondrial respiration measurements using a Seahorse XFp analyzer.</p><p><strong>Results: </strong>We present the clinical and functional characterization of a novel homozygous <i>ISCA2</i> missense variant (NM_194279.3:c.70A>G:p.Arg24Gly), leading to aberrant splicing in a patient presenting with neuroregression, generalized spasticity with exaggerated deep tendon reflexes and head lag, and progressive loss of acquired milestones. The novel variant was fully segregated in a wider family and was absent in a large control cohort, ethnically matching in-house exomes, local databases such as CGMdb and Saudi Human Genome Program, and ClinVar.</p><p><strong>Conclusions: </strong>Our analyses revealed that the variant is pathogenic, disrupting normal <i>ISCA2</i> splicing and presumably leading to a truncated protein that disturbs metabolic pathways in patient-derived cells.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561297/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A bibliometric and visual analysis of Parkinson's disease sleep disorders: articles from 2008 to 2023. 帕金森病睡眠障碍的文献计量和视觉分析:2008 年至 2023 年的文章。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2024-10-17 eCollection Date: 2024-01-01 DOI: 10.3389/fpsyt.2024.1468568
Lili Zhu, Peiyuan Zhu, Juwei Wang, Kaiwen Yan, Sheng Zhao, Yue Jiang, Huihe Zhang

Objective: Sleep disorder is a common non-motor symptom (NMS) of Parkinson's disease. However, the global research focus on Parkinson's sleep-related disorders (PDSDs) and future trends remains unclear. Currently, there is no bibliometric analysis of PDSDs. We aim to fill this gap, determine the status of current research, and predict future research hotspots.

Methods: We selected 1490 publications from the Web of Science Core Collection (WoSCC) database from 2008 to 2023. Based on CiteSpace and VOSviewer, the analysis was performed from the perspectives of the trend in the number of annual publications, countries, institutions, authors, journals, and co-citations.

Results: A total of 1490 publications from 590 authors from 409 institutions in 77 countries are included. The United States, China, and the United Kingdom are the leading countries. University College London (UCL) is the most prolific institution. Harvard University is the key for cooperation among institutions. Chaudhuri Kallol Ray is a leader in this field. "Movement Disorders" is the most influential journal. "A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015" is the publication with the highest co-citation intensity.

Conclusion: The total volume of publications on PDSDs is on the rise, entering a relatively high-yield stage in 2020. The COVID-19 pandemic and the emergence of new keywords may be the reasons behind this phenomenon. "quality of life" and "circadian rhythm" are the mainstream topics of PDSD research. Daytime sleepiness is the PDSD subtype that has received the most attention. Sleep quality, biomarkers, and neurodegeneration are likely to become future research hotspots.

目的:睡眠障碍是帕金森病常见的非运动症状(NMS):睡眠障碍是帕金森病常见的非运动症状(NMS)。然而,全球对帕金森睡眠相关障碍(PDSDs)的研究重点和未来趋势仍不明确。目前,还没有关于帕金森睡眠相关障碍的文献计量分析。我们旨在填补这一空白,确定当前的研究状况,并预测未来的研究热点:我们从 Web of Science Core Collection(WoSCC)数据库中选取了 2008 年至 2023 年间的 1490 篇出版物。基于CiteSpace和VOSviewer,我们从年度出版物数量趋势、国家、机构、作者、期刊和联合引用等角度进行了分析:共收录了来自 77 个国家 409 个机构 590 位作者的 1490 篇论文。美国、中国和英国是发表论文最多的国家。伦敦大学学院(UCL)是发表论文最多的机构。哈佛大学是机构间合作的关键。Chaudhuri Kallol Ray 是这一领域的领军人物。"运动障碍 "是最有影响力的期刊。"2005-2015年帕金森病睡眠和觉醒障碍文献的系统回顾 "是联合引用强度最高的出版物:结论:有关帕金森病的论文总量呈上升趋势,2020 年将进入相对高产阶段。COVID-19大流行和新关键词的出现可能是这一现象背后的原因。"生活质量 "和 "昼夜节律 "是 PDSD 研究的主流主题。白天嗜睡是最受关注的 PDSD 亚型。睡眠质量、生物标志物和神经变性可能成为未来的研究热点。
{"title":"A bibliometric and visual analysis of Parkinson's disease sleep disorders: articles from 2008 to 2023.","authors":"Lili Zhu, Peiyuan Zhu, Juwei Wang, Kaiwen Yan, Sheng Zhao, Yue Jiang, Huihe Zhang","doi":"10.3389/fpsyt.2024.1468568","DOIUrl":"https://doi.org/10.3389/fpsyt.2024.1468568","url":null,"abstract":"<p><strong>Objective: </strong>Sleep disorder is a common non-motor symptom (NMS) of Parkinson's disease. However, the global research focus on Parkinson's sleep-related disorders (PDSDs) and future trends remains unclear. Currently, there is no bibliometric analysis of PDSDs. We aim to fill this gap, determine the status of current research, and predict future research hotspots.</p><p><strong>Methods: </strong>We selected 1490 publications from the Web of Science Core Collection (WoSCC) database from 2008 to 2023. Based on CiteSpace and VOSviewer, the analysis was performed from the perspectives of the trend in the number of annual publications, countries, institutions, authors, journals, and co-citations.</p><p><strong>Results: </strong>A total of 1490 publications from 590 authors from 409 institutions in 77 countries are included. The United States, China, and the United Kingdom are the leading countries. University College London (UCL) is the most prolific institution. Harvard University is the key for cooperation among institutions. Chaudhuri Kallol Ray is a leader in this field. \"Movement Disorders\" is the most influential journal. \"A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015\" is the publication with the highest co-citation intensity.</p><p><strong>Conclusion: </strong>The total volume of publications on PDSDs is on the rise, entering a relatively high-yield stage in 2020. The COVID-19 pandemic and the emergence of new keywords may be the reasons behind this phenomenon. \"quality of life\" and \"circadian rhythm\" are the mainstream topics of PDSD research. Daytime sleepiness is the PDSD subtype that has received the most attention. Sleep quality, biomarkers, and neurodegeneration are likely to become future research hotspots.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1